QurAlis to tap $88M funding to develop ALS product candidates,QurAlis announced that it has...
Neurological Disease
App could soon provide at-home test for brain diseases via 'eye selfies',Researchers at the...
Reata sets $370,000 annual cost for new nerve disorder drug,Reata Pharmaceuticals has won FDA...
Algernon to explore psychedelic as traumatic brain injury treatment,Algernon announced its plans to explore...
CMS restricts coverage of amyloid-targeting Alzheimer's antibodies,CMS has denied the Alzheimer's Association's request asking...
People can have food sensitivities without noticeable symptoms – long-term consumption of food allergens...
People produce endocannabinoids – similar to compounds found in marijuana – that are critical...
Phase 3 study shows zavegepant can relieve migraine pain quickly,The Lancet has published Phase 3...
Neuron23 launches clinical trial for NEU-723 in Parkinson's,South San Francisco–based Neuron23 has started the...
